The increased expression of ERK1/2 is suggestive of tumor progression, and its co-expression with TRPV4 on the same DRG neuronal cells was also confirmed, inferring the mutual synergistic roles of these proteins in pain transduction. The gene discussed is MAPK3; the disease is neoplasm.